The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions

A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia (CME)

(2012) Kathryn E. Webert et al.   TRANSFUSION

A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion

(2011) Miguel Lozano et al.   BRITISH JOURNAL OF HAEMATOLOGY

Adjudicating bleeding events in a platelet dose study: impact on outcome results and challenges

(2011) Nancy M. Heddle et al.   TRANSFUSION

Determination of acute lung injury after repeated platelet transfusions

(2010) L. Corash et al.   BLOOD

Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage

(2010) Sherrill J. Slichter et al.   NEW ENGLAND JOURNAL OF MEDICINE

A systematic assessment of the quality of reporting for platelet transfusion studies

(2010) Meghan Delaney et al.   TRANSFUSION

Time to rethink clinically important outcomes in platelet transfusion trials

(2010) Nancy M. Heddle et al.   TRANSFUSION

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

(2010) J-P. Cazenave et al.   TRANSFUSION

Do All Patients With Hematologic Malignancies and Severe Thrombocytopenia Need Prophylactic Platelet Transfusions?

(2010) Simon J. Stanworth et al.   TRANSFUSION MEDICINE REVIEWS

A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia

(2008) N. M. Heddle et al.   BLOOD